1. Home
  2. NCNO vs AAPG Comparison

NCNO vs AAPG Comparison

Compare NCNO & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNO
  • AAPG
  • Stock Information
  • Founded
  • NCNO 2011
  • AAPG 2009
  • Country
  • NCNO United States
  • AAPG China
  • Employees
  • NCNO 1833
  • AAPG N/A
  • Industry
  • NCNO Computer Software: Prepackaged Software
  • AAPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCNO Technology
  • AAPG Health Care
  • Exchange
  • NCNO Nasdaq
  • AAPG Nasdaq
  • Market Cap
  • NCNO 3.2B
  • AAPG 3.6B
  • IPO Year
  • NCNO 2020
  • AAPG 2025
  • Fundamental
  • Price
  • NCNO $29.08
  • AAPG $47.90
  • Analyst Decision
  • NCNO Buy
  • AAPG Buy
  • Analyst Count
  • NCNO 16
  • AAPG 1
  • Target Price
  • NCNO $31.33
  • AAPG N/A
  • AVG Volume (30 Days)
  • NCNO 1.3M
  • AAPG 8.1K
  • Earning Date
  • NCNO 08-26-2025
  • AAPG 08-20-2025
  • Dividend Yield
  • NCNO N/A
  • AAPG N/A
  • EPS Growth
  • NCNO N/A
  • AAPG N/A
  • EPS
  • NCNO N/A
  • AAPG N/A
  • Revenue
  • NCNO $556,707,000.00
  • AAPG $54,524,554.00
  • Revenue This Year
  • NCNO $9.70
  • AAPG N/A
  • Revenue Next Year
  • NCNO $8.80
  • AAPG $404.41
  • P/E Ratio
  • NCNO N/A
  • AAPG N/A
  • Revenue Growth
  • NCNO 13.39
  • AAPG N/A
  • 52 Week Low
  • NCNO $18.75
  • AAPG $16.50
  • 52 Week High
  • NCNO $43.20
  • AAPG $48.45
  • Technical
  • Relative Strength Index (RSI)
  • NCNO 57.84
  • AAPG N/A
  • Support Level
  • NCNO $27.38
  • AAPG N/A
  • Resistance Level
  • NCNO $28.25
  • AAPG N/A
  • Average True Range (ATR)
  • NCNO 0.81
  • AAPG 0.00
  • MACD
  • NCNO 0.14
  • AAPG 0.00
  • Stochastic Oscillator
  • NCNO 98.87
  • AAPG 0.00

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflows and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposits, and other accounts, and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. The company generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: